Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P90
Near historical high
vs 2Y Ago
168.2x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 30.89% |
| Q3 2025 | -19.54% |
| Q2 2025 | 31.84% |
| Q1 2025 | -41.88% |
| Q4 2024 | -26.45% |
| Q3 2024 | 38.04% |
| Q2 2024 | 21.81% |
| Q1 2024 | -44.52% |
| Q4 2023 | 0.18% |
| Q3 2023 | 15.28% |
| Q2 2023 | 1.90% |
| Q1 2023 | -30.72% |
| Q4 2022 | -24.07% |
| Q3 2022 | 20.89% |
| Q2 2022 | 3.56% |
| Q1 2022 | -38.79% |
| Q4 2021 | 8.85% |
| Q3 2021 | -5.90% |
| Q2 2021 | 12.96% |
| Q1 2021 | 15.03% |
| Q4 2020 | -47.41% |
| Q3 2020 | -40.25% |
| Q2 2020 | 36.89% |
| Q1 2020 | -15.16% |
| Q4 2019 | -31.86% |
| Q3 2019 | -23.24% |
| Q2 2019 | -17.76% |
| Q1 2019 | 6.06% |
| Q4 2018 | -12.16% |
| Q3 2018 | -16.64% |
| Q2 2018 | -36.20% |
| Q1 2018 | 14.52% |
| Q4 2017 | 3.70% |
| Q3 2017 | -23.90% |
| Q2 2017 | 10.61% |
| Q1 2017 | -51.96% |
| Q4 2016 | 0.27% |
| Q3 2016 | -240.19% |
| Q2 2016 | 16.51% |
| Q1 2016 | 32.33% |